Objectives. First study. Second Study. Determination of Unspecific Sensitivity
|
|
- Holly Goodman
- 5 years ago
- Views:
Transcription
1 Institute and Outpatient Clinic for Occupational and Social Medicine University of Heidelberg Formaldehyde and chemosensory effects in normal, hyper and hyposensitive volunteers G. Triebig, I. Lang, J. U. Mueller, T. Bruckner Objectives to examine chemosensory effects of formaldehyde on normal, hyper and hyposensitive healthy, non smoking men and woman symptoms and findings on eyes, nose and olfactory function exposed to concentrations typical for workplaces: up to. ppm th International Congress on Occupational Health March 8, Cancun, Mexico Studies were approved by the Ethics Committee of the Medical Faculty of the University of Heidelberg First study Exposure/ Concentrations men and woman 6 +/ 6 years old students, unemployed persons Subjects Exposure Monday to Friday Two consecutive weeks (= days) Four hours daily Random order and double blind fashion Masking with ethylacetat Examinations after min, min and 9 min of exposure Scenario Formaldehyde Continuous exposure (ppm) Formaldehdye peaks (ppm) x.6 x. x. EA (ppm) men +/ years old unemployed persons Second Study Subjects Exposure Exposed on consecutive days (Monday Friday), hours daily followup examinations at oneweekintervals five randomized formaldehyde concentrations: concentration A:. ppm (control group) concentration B:. ppm with.6 ppm peak ( x min) concentration C:. ppm with.8 ppm peak ( x min) concentration D:. ppm concentration E:.7 ppm Determination of Unspecific Sensitivity COthreshold measurement / Separation into Sensitivity Groups CO offers possibility to determine irritation of trigeminal nerve (=sensible nerve supply e.g. of the nose) COapplication at nasal mucosa evokes stinging, painful sensations (concentration and sensitivitydependent) provoked subjective pain intensities marked on a VAscale (by participant) were used for mathematical calculation of individual sum score ( individual sensitivity score ), and for evaluation of mean value, median and quartiles. on basis of these individual sum scores of our volunteers Separation into two subgroups. at median hyposensitive and hypersensitive participants. at upper/ lower quartile resp. extremely hypo / hypersensitive subjects
2 Examinations: examinations and volunteers Subjective rating Swedish Performance Evaluation System (SPES) by Gamberale et al. 989, German version by Seeber et al. Digital slit lamp photography: conjunctival redness grading scale of the Cornea and Contact Lens Research Unit (CCLRU) Measurement of blinking frequency new developed method by Ziegler et al. 7 (Exposure chamber) Tear film break up time (stopwatch measurement) Olfactory function (nbutanol threshold, SniffinSticks) Active anterior rhinomanometry nasal flow and resistance (Volunteers on cycle ergometer in exposure chamber) examinations and volunteers SPES I (Video recording of eyeblinking frequency) (Test of olfactory function Sniffin Sticks ). Blurred Sight. Feeling of fainting or vertigo. Pain or pressure over the chest. Bad taste in the mouth. Sensation of bad air (quality) 6. Irritation of the throat 7. Headache 8. Coughing spells 9. Sensation of unpleasant taste. Nasty smell. Irritation of the skin. Dizziness. Shortness of breath. Nasty taste. Palpitations 6. Sensation of unpleasant smell 7. Nausea 8. Stink 9. Irritation of the nose. Itching nose. Dry nose. Running nose. Smarting nose. Diplopic images. Eyestrain 6. Itching eyes 7. Smarting eyes 8. Irritation of the eyes 9. Dry eyes. Watering eyes. Redness of the eyes = not at all = hardly at all = somewhat = rather much = considerably = very, very much SPES II SPES III S y m p to m g r o u p S y m p to m s O lfactory sym ptom s Sensation of bad air (quality ) N a s ty s m e ll S e n s a tio n o f u n p le a s a n t s m e ll S tin k Nasal irritations Irritation of the nose Itc h in g n o s e D ry n o s e R u n n in g n o s e S m a rtin g n o s e O c u la r irrita tio n s E y e s tra in Itc h in g e y e s S m a rtin g e y e s Irritation of the eyes D ry e y e s W a te ry e y e s R e d n e s s o f th e e y e s S h a m e s y m p to m s P a lp ita tio n s D ip lo p ic im a g e s Symptom group Unspecific symptoms Not classified Taste symptoms Respiratory symptoms Symptoms Feeling of fainting or vertigo Dizziness Nausea Blurred sight Irritation of the throat Irritation of the skin Bad taste in the mouth Sensation of unpleasant taste Nasty taste Pain or pressure over the chest Coughing spells Shortness of breath
3 Results Study I: Eye Irritation Results Study II: Eye Irritation A = ppm B =.ppm C =.ppm D =.ppm + peaks with.6ppm E =.ppm F =.ppm + peaks with.ppm G = ppm + EA H =.ppm + EA I =.ppm + EA K =.ppm + peaks with.ppm + EA * compared to FA # compared to FA + EA Postexposure Eye Irritation scores are predominantly increased compared to values before exposure, however, without statistical significance and without a concentrationresponserelationship. Comparison to the zero concentration and comparison between the sensitivity groups also revealed no statistical significant difference. Results Study I: Nasal Irritation Results Study II: Nasal Irritation (= combined organ related items/symptoms; e.g. burning, running or dry nose) A = ppm B =.ppm C =.ppm D =.ppm + peaks with.6ppm E =.ppm F =.ppm + peaks with.ppm G = ppm + EA H =.ppm + EA I =.ppm + EA K =.ppm + peaks with.ppm + EA * compared to FA # compared to FA + EA We found no uniform trend and no significant changes in postexposure values. No concentrationresponse relationship could be detected. Comparison to the zero concentration and comparison between the sensitivity groups also revealed no consistent tendency. Results Study I: Olfactory Symptoms (= combined organ related items/symptoms; e.g. stench, unpleasant smell or perception of impure air) Olfactory Symptoms is the very SPESSubgroup with strongest increase of symptomscores after exposure A = ppm B =.ppm C =.ppm D =.ppm + peaks with.6ppm E =.ppm F =.ppm + peaks with.ppm G = ppm + EA H =.ppm + EA I =.ppm + EA K =.ppm + peaks with.ppm + EA * compared to FA # compared to FA + EA Results Study II: Olfactory Symptoms Generally, all volunteers indicate an increase of olfactory symptoms after exposure (including controlgroup) Higher increases were found in hypersensitive and extremely hypersensitive volunteers compared to hypo / extremely hyposensitive counterparts. However Comparison with zeroconcentration reveals only few statistically significant differences and no consistent concentrationresponse relationship. rather a situational effect than attributable to formaldehyde effects see following page
4 Results Study I: Conjunctival Redness Eye redness according to CCLRU Eye redness grade A = ppm B =.ppm C =.ppm D =.ppm + peaks with.6ppm E =.ppm F =.ppm + peaks with.ppm G = ppm + EA H =.ppm + EA I =.ppm + EA K =.ppm + peaks with.ppm + EA * p <. = very slight = slight = moderate = severe Results Study I: Blinking Frequency Blinking frequency per 9 sec Results Study I: Correlation between blinking frequency and eye irritations Formaldehyde concentration (ppm) Mean blinking frequency ±SD Median Range... + peaks at.6 8. ±.. ±. 7.8 ±.7. ± ρ=.6; y =.9x +.7 p=... + peaks at. + EA. + EA. + EA. + peaks at. + EA 9. ± ±.6 *# 8.6 ± ±.. ±.. ±. *# Results Study II: Blinking Frequency Results Study II: Tearfilm BreakUp Time No concentrationdependent increase of eye blinking frequency after FA exposure No statistically significant differences between pre and postexposure values in comparison with zero concentration between different sensitivity groups We found an increase rather than a decrease of tear film breakup time after exposure. Comparison with control group and comparison between the sensitivity groups revealed no consistent tendency and no concentrationeffect relationship
5 Results Study I: Nasal Flow Results Study II: Olfactory Funktion nbutanol threshold (performed daily before/after exposure and during the followup examinations) 6 A = ppm B =.ppm C =.ppm D =.ppm + peaks with.6ppm E =.ppm F =.ppm + peaks with.ppm G = ppm + EA H =.ppm + EA I =.ppm + EA K =.ppm + peaks with.ppm + EA 6 A B C D E F G H I K No consistent, concentrationdependent pre/postexposure change of nbutanol thresholds No significant differences compared to control group and no concentrationeffect relationship detectable. No significant variation of nbutanol thresholds between different sensitivity groups Conclusion: no specific FAeffect detectable! Results Study I: Time course A) Ocular irritation A = No exposure B =. ppm plus peaks of. ppm C = Next morning (about 6hrs after exposure) * p<. Conclusions () Eye irritations are the most critical effects induced by formaldehyde vapors Blink frequency and redness of the eyes increased significantly at a concentration of. ppm with peaks of. ppm Peak exposure is more relevant to induce conjunctival effects B) Olfactory irritation A = No exposure B =. ppm plus peaks of. ppm C = Next morning (about 6hrs after exposure) * p<. Eye and olfactory symptoms started at concentrations of. ppm without peaks Conclusions () Acknowledgement No influence of gender on results No significant differences of specific effect parameters between hypo and hypersensitive persons NOAELs of. ppm (constant exposure) and,8 ppm (shortterm peaks) are recommended Our results are in accordance with former review articles of Paustenbach et al. (997) () and Arts et al. (6) () We gratefully acknowledge the volunteers for their participation and the following colleagues for assistance and study advice: Lutz Buchholz, Gudula Christ, Armin Gamer, HeinzPeter Gelbke, Joerg Haisser, Thomas Hummel, Michael Kentner, Christoph Klingmann, Stefan Knohl, Thomas Krczal, Heidi Ludwig, Jutta Martin, Sylvana Müller, Wolfgang Rosenberger, Manuel Ruehle, Benno Schuster, Guenter Speit, Rho Thiel, Andrea Vinzens und Holger Zimmer. The authors thank the FormaCare sector group of CEFIC, Brussels, the European Panel Federation, Brussels, and the Verband der Deutschen Holzwerkstoffindustrie e.v., Gießen, for their financial support of this study. J.Toxicol.Environ.Health (997) 76 Regul.Toxicol.Pharmacol. (6) 6
6 Publications Isabelle Lang, Thomas Bruckner, Gerhard Triebig: Formaldehyde and chemosensory irritation in humans: A controlled human exposure study, Regulatory Toxicology and Pharmacology (8) 6. Joerg U. Mueller, Thomas Bruckner, Gerhard Triebig: Exposure study to examine chemosensory effects of formaldehyde on hyposensitive and hypersensitive males, International Archives of Occupational and Environmental Health, DOI.7/s79. Thank you for your attention! 6
Susceptibility towards formaldehyde-induced genotoxicity. Günter Speit
Susceptibility towards formaldehyde-induced genotoxicity Günter Speit Universität Ulm Institut für Humangenetik D-89069 Ulm (Germany) guenter.speit@uni-ulm.de CEFIC-2012 Günter Speit 1 Susceptibility towards
More informationVinyl Chloride Exposure Study of the Community and Local Emergency Responders
NATIONAL TRANSPORTATION SAFETY BOARD - Public Hearing Conrail Derailment in Paulsboro, NJ with Vinyl Chloride Release GROUP 7 EXHIBIT O Agency / Organization State of New Jersey Department of Health Title
More informationGenotoxicity of formaldehyde in vitro and in vivo. Günter Speit
Genotoxicity of formaldehyde in vitro and in vivo Günter Speit Universität Ulm Institut für Humangenetik D-89069 Ulm (Germany) guenter.speit@uni-ulm.de CEFIC-2012 Günter Speit 1 Genotoxicity of formaldehyde
More informationTIMALEN 0.5% eye drops
PACKAGE LEAFLET: INFORMATION FOR THE USER TIMALEN 0.5% eye drops TIMOLOL (AS TIMOLOL MALEATE) This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,
More informationPatient History (Please Print)
Patient History (Please Print) Date: Name: Email: Phone: (Home) (Mobile) (Work) Address: City: Zip: Birth Date: / / Male Female Spouse/Parent Name: # of Children: Married Single Divorced Widowed Are you
More informationPATIENT INFORMATION LEAFLET. Nasoxyl nasal spray solution 1 mg/ml
PATIENT INFORMATION LEAFLET Nasoxyl nasal spray solution 1 mg/ml Read all of this leaflet carefully, because it contains important information for you. This medicine is available without prescription.
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP Read this carefully before you start taking IOPIDINE 1% and each
More informationIndoor Environment Quality and Health. Leila Kakko TAMK
Indoor Environment Quality and Health Leila Kakko TAMK Indoor Environmental Quality (IEQ) described as the conditions inside a building. entire environmental quality of a space air quality access to daylight
More informationAmarillo Surgical Group Doctor: Date:
Office Visit Information (General Surgery) Amarillo Surgical Group Doctor: Date: Patient s Information Name: Last First Middle Social Security #: Date of Birth: Age Gender: [ Male / Female ] Marital Status:
More informationSUPPLEMENTARY INFORMATION
SUPPLEMENTARY INFORMATION Contents METHODS... 2 Inclusion and exclusion criteria... 2 Supplementary table S1... 2 Assessment of abnormal ocular signs and symptoms... 3 Supplementary table S2... 3 Ocular
More informationOPINION of the French Agency for Food, Environmental and Occupational Health & Safety
The Director General Maisons-Alfort, 2 February 2018 OPINION of the French Agency for Food, Environmental and Occupational Health & Safety on the revision of ANSES's reference values for formaldehyde:
More informationEssential Wellness Of Illinois, LLC Health History Questionnaire Christine A. Renz L.Ac., Dipl OM, MSTOM
Name Date Address City State Zip Home Phone Cell Fax Email Emergency Contact Emergency Number Date of Birth Age Sex Height Weight Lbs Marital Status Occupation Who referred you to this office? Name of
More informationH302 + H332: Harmful if swallowed or inhaled
Section 1: Identification DATE OF LAST REVISION: 06/29/15 Product Name: Zinc Telluride CAS Number: 1315-11-3 / EC Number: 215-260-2 Company: Angstrom Sciences, Inc. 40 South Linden Street Duquesne, PA
More informationOELs and Sensation: Irritation or Odor as basis for an OEL; do's and don't's
OELs and Sensation: Irritation or Odor as basis for an OEL; do's and don't's Dr. Kirsten Sucker MEDICHEM 2016, Basel, 01.09.2016 Irritant-Research: Quality assured limit values for prevention More than
More informationInner Balance Acupuncture
Patient Information Inner Balance Acupuncture 274 Southland Drive, Suite 101, Lexington, KY 40503 859-595-2164 www.acupunctureky.com Name: Today s date: Age: Male Female Marital status: Date of Birth:
More informationClinical Study Report SLO-AD-1 Final Version DATE: 09 December 2013
1. Clinical Study Report RANDOMIZED, OPEN, PARALLEL GROUP, PHASE IIIB STUDY ON THE EVALUATION OF EFFICACY OF SPECIFIC SUBLINGUAL IMMUNOTHERAPY IN PAEDIATRIC PATIENTS WITH ATOPIC DERMATITIS, WITH OR WITHOUT
More informationSafety Data Sheet. Product Name: Product Number: Product Identity. 2. Hazardous Ingredients. Formaldehyde: CAS: Methanol: CAS:
Olathe, KS Tel: 913-390-6184 Safety Data Sheet Solution (Formalin, Formol, Methanol, Formaldehyde containing solutions, Formalith) Emergency phone: 800 424 9300 (Chemtrec) NFPA Rating: Health 3, Flammability
More informationAtrovent Administration
Atrovent Administration ICEMA Training 2007 Sherri Shimshy RN OBJECTIVES Describe the pharmacology of Atrovent Identify the indications for use of Atrovent in the Adult Population Identify the indications
More informationWARNING! FLAMMABLE. Keep away from open flame. WARNING! IRRITANT. May be irritating to skin and mucous membranes.
SAFETY DATA SHEET Health 1 Flammability 1 Reactivity 0 Protective Equipment B SECTION 1 PRODUCT AND COMPANY INFORMATION MANUFACTURER S NAME EMERGENCY TELEPHONE NUMBER Nueva Generacion Manufacturas S.A
More informationNew Patient Questionnaire
- - Toda y 's Date: Primary Care Provider's Name: Was a consultation recommended? Primary Clinic: Referring provider's name (if different): Please answer the following questions to facilitate the diagnosis
More informationMATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET 1. IDENTIFICATION OSTREM CHEMICAL CO. LTD. Phone: 780-440-1911 or 780-446-0177 2310-80 AVENUE In Case of Emergency Only: EDMONTON AB T6P 1N2 phone CANUTEC at (613) 996-6666 Product
More informationGreenline Plywood Products Ltd.
Greenline Plywood Products Ltd. MATERIAL SAFTY DATA SHEET SECTION #1 COMPANY IDENTIFICATION Name: Fineline Reconstituted Wood Veneer Date: August 15, 2007 Wood: Fineline Company Information Greenline Plywood
More informationVCU CENTER FOR SLEEP MEDICINE NEW PATIENT QUESTIONNAIRE
VCU CENTER FOR SLEEP MEDICINE NEW PATIENT QUESTIONNAIRE Name:_ DOB: MR#: Date: Sex: Age: Height: Referring physician: Primary care physician: What is your primary sleep problem? Please explain any strange
More informationPatient Intake Form for Acupuncture Treatment at Infinite Healing
Section A: Your Information Patient Intake Form for Acupuncture Treatment at Infinite Healing Last Name: First Name: Middle Initial: Mailing Address: _ City: Postal Code: E-mail: Birth date: M D YR Age:
More informationREPORT OF USE TEST UNDER DERMATOLOGIST AND OPHTHALMOLOGIST CONTROL
Client: PHENICOPTERE SP. Z O.O. ul. Nowogrodzka 18a/21 00-511 Warszawa Sample (according to declaration of the Client) EYE MAKE-UP REMOVAL GLOVE Sample received on: 06.03.2015 Analysis completed on: 08.04.2015
More informationFormaldehyde and Cancer: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Formaldehyde and Cancer:
More informationPackage Leaflet : Information for the User. IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride)
Package Leaflet : Information for the User IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You
More informationDry Eye Assessment and Management Study ELIGIBILITY OCULAR EVALUATION FORM
Page 1 of 13 BEFORE COMPLETING THE OCULAR EXAMINATION, YOU MUST BE ABLE TO ANSWER YES TO THE FOLLOWING QUESTIONS: Have you done MMP9? (SVonly) The Following are done at Baseline: Have you done Tear Osmolarity?
More informationExercise and Air Pollution
Exercise and Air Pollution Two Major Groups of Air Pollutants Primary From a single source of pollution CO, sulfur oxides, nitrogen oxides, hydrocarbons, particulants Secondary Result from an interaction
More informationCECILIA P MARGRET MD PhD MPH Child, Adolescent and Adult Psychiatry NE 24th ST Suite 104, Bellevue WA 98007, Phone / Fax: +1 (425)
IDENTIFYING INFORMATION PATIENT INFORMATION FORM Patient's Name: DOB: Ethnicity/race: Gender: Primary language if other than English: Address: Phone: Home/ Mobile/ Work Email: Occupation: Marital Status:
More informationCaspian Acupuncture -- Health History Form Anita Tayyebi EAMP, LAc. 652 SW 150 th St Burien WA 98166
Frist Name Last: Date Phone (H) (C) (W) E-mail Address City State Zip Age DOB Place of Birth _ Marital/Partnership Status Preferred Gender Pronoun _ Profession Family Physician Telephone # Referred By
More informationA survey of eye-related complaints among call-center employees in Pune
Original article: A survey of eye-related complaints among call-center employees in Pune 1 Dr Shitole Satish C, 2 Dr Deshmukh S * 1 Assistant Professor, Department of Ophthalmology, B J Government medical
More informationInvestigating and diagnosing patients who have been exposed to cabin fume events
FEDERAL INSTITUTE FOR RISK ASSESSMENT Investigating and diagnosing patients who have been exposed to cabin fume events Nina Glaser Federal Institute for Risk Assessment (BfR) Working Fields /Departments
More informationWhat do I need to tell my doctor BEFORE I take this drug?
PATIENT & CAREGIVER EDUCATION Durvalumab Brand Names: US Imfinzi Brand Names: Canada Imfinzi What is this drug used for? It is used to treat cancer in the bladder or urinary tract. It is used to treat
More informationChinese Medicine Adult Intake Form. Name (Last, First): Home address: Phone: Emergency contact name & phone number: Relationship Status:
Chinese Medicine Adult Intake Form Name (Last, First): Date of Birth: Occupation: Hours per week: Home address: Phone: Email: Preferred contact method (circle one): Phone / Email Emergency contact name
More informationAPO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride)
APO-Olopatadine Eye Drops Contains the active ingredient olopatadine (as olopatadine hydrochloride) Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet
More informationZINC SELENIDE SAFETY DATA SHEET DATE OF LAST REVISION: 07/07/15. Section 1: Identification
Section 1: Identification ZINC SELENIDE DATE OF LAST REVISION: 07/07/15 Product Name: Zinc Selenide CAS Number: 1315-09-9 / EC Number: 215-259-7 Company: Angstrom Sciences, Inc. 40 South Linden Street
More informationDry eye syndrome. Lacrimal gland. Tear duct into nose. 1 of 6
Dry eye syndrome The aim of this information sheet is to answer any questions you may have about dry eye syndrome. If you have any further questions or concerns, please ask a doctor or nurse caring for
More informationDorzolamide 20 mg/ml Eye Drops, Solution
PACKAGE LEAFLET: INFORMATION FOR THE USER Dorzolamide 20 mg/ml Eye Drops, Solution (Dorzolamide hydrochloride) Read all of this leaflet carefully before you start using this medicine because it contains
More informationDate of Assessment: Assessed By: Questionnaire: Assessing Student Readiness to Self- Carry
Student Name: Score: Date of Assessment: Assessed By: naire: Assessing Student Readiness to Self- Carry Having immediate access to quick- relief medicine is critical for people with asthma. The purpose
More informationPackage leaflet: Information for the user. Zonnic Pepparmint 1 mg/spraying oromucosal spray Nicotine
Package leaflet: Information for the user Zonnic Pepparmint 1 mg/spraying oromucosal spray Nicotine Read all of this leaflet carefully before you start using this medicine because it contains important
More informationPackage leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine
Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine Read all of this leaflet carefully before you start taking this medicine because
More informationUnit 4 - REGULATORY SYSTEMS Special Senses Lecture Notes
Unit 4 - REGULATORY SYSTEMS Special Senses Lecture Notes 4.04 Describe the Special Senses A. Smell Smell occurs when specialized cells in the nose (chemoreceptors) detect certain chemicals resulting in
More informationOriental Medicine Questionnaire
Oriental Medicine Questionnaire Date: Name: DOB Sex: M F SS# Address: City State Zip Cell Phone: Home Phone: Business Phone Occupation: Height: Weight: Who referred you to this office? 1.What brought you
More informationBlack mold and itching
P ford residence southampton, ny Black mold and itching Jan 16, 2018. Exhausted by itchy bites, crawling and pinprick sensations, and something invisible landing on your skin? Mystery solved: Here is how
More information1.0 Presenting complaint: Onset 1.1 When it started? 1.2 How did it start? Progress 1.3 Has the problem increased /decreased so far?
Case history Sr. No. Name Sex M / F Age Marital Status B / S / M / W Occupation Date 1.0 Presenting complaint: Onset 1.1 When it started? 1.2 How did it start? Progress 1.3 Has the problem increased /decreased
More informationMast Cell Activation Syndrome
Mast Cell Activation Syndrome Clinical Questionnaire Description Today s Date: Patient Name: Please indicate yes or no for the following symptoms and traits: (If you are not familiar with a particular
More informationNEW PATIENT INFORMATION FORM
NEW PATIENT INFORMATION FORM Name: LAST FIRST MIDDLE Date of Birth: Sex: Marital Status: SS Number: Address: City: State: Zip Phone: Home Cell Work Email: Communication Preference: Patient Portal Phone
More information3855 Burton Street SE Suite A, Grand Rapids, MI Phone Fax Patient Information. Address: City: State: Zip:
3855 Burton Street SE Suite A, Grand Rapids, MI 49546 Phone 616.323.3102 Fax 616.323.3061 Patient Information Patient Name: Preferred Language: Address: City: State: Zip: Home Phone: Cell Phone: Cell Carrier:
More informationShelley Westwood, RN, BSN
Shelley Westwood, RN, BSN The body requires a constant supply of oxygen for survival. AMERICAN RED CROSS FIRST AID RESPONDING TO EMERGENCIES FOURTH EDITION Copyright 2006 by The American National Red Cross
More information2. Approx. Date of Onset: 3. Approx. Date of Onset:
Healthy Balance Lisa A. Dulac, L.Ac. Acupuncture Patient Intake Form Present Health Concerns: Please list your most important health concerns in order of their significance. 1. Approx. Date of Onset: 2.
More informationPackage leaflet: information for the user Nicorette Microtab 2 mg sublingual tablets. Nicotine
Nicorette Microtab for packaging containing blister Package leaflet: information for the user Nicorette Microtab 2 mg sublingual tablets Nicotine Read all of this leaflet carefully before you start using
More informationContinued Low Symptom Prevalence One Year and Three Years after a Costly Restoration of an Apartment Building with Severe Indoor Climate Problems
Continued Low Symptom Prevalence One Year and Three Years after a Costly Restoration of an Apartment Building with Severe Indoor Climate Problems Göran Stridh 1,*, Kjell Andersson 2 and Inger Fagerlund
More informationIt may be g iven to you for other reasons. Talk with the doctor. What do I need to tell my doctor BEFORE I take this drug?
PATIENT & CAREGIVER EDUCATION Bendamustine Brand Names: US Bendeka; Treanda Brand Names: Canada Treanda What is this drug used for? It is used to treat a type of leukemia. It is used to treat a type of
More informationMATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET SECTION 1: PRODUCT AND COMPANY IDENTIFICATION Product Name: BH 1151 FRB Manufacturer: Federal-Mogul Corporation 26555 rthwestern Highway Southfield, MI 48033 MSDS# BH-029 24hr
More informationPackage leaflet: Information for the patient. Cetirizin Sandoz 10 mg film-coated tablets. cetirizine dihydrochloride
Package leaflet: Information for the patient Cetirizin Sandoz 10 mg film-coated tablets cetirizine dihydrochloride [For medicine available only on prescription:] Read all of this leaflet carefully before
More informationFREQUENTLY ASKED QUESTIONS SWINE FLU
FREQUENTLY ASKED QUESTIONS SWINE FLU Updated 5/6/09 ER FAQ What is swine flu? Swine flu is common disease of pigs and is caused by the same category of influenza virus (influenza A) that causes flu in
More informationEFFECTS ON PERFORMANCE AND WORK QUALITY DUE TO LOW FREQUENCY VENTILATION NOISE
Journal of Sound and Vibration (1997) 205(4), 467 474 EFFECTS ON PERFORANCE AND WORK QUAITY DUE TO OW FREQUENCY VENTIATION NOISE K. PERSSON WAYE, R. RYANDER Department of Environmental edicine, Go teborg
More informationMATERIAL SAFETY DATA SHEET WOOD VENEERS August, 2017
MATERIAL SAFETY DATA SHEET WOOD VENEERS August, 2017 This Material Safety Data Sheet (MSDS) has been prepared by the Timber Veneer Association of Australia (TVAA) in accordance with the National Code of
More informationREAD THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] Mepolizumab for Injection
READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr NUCALA [new-ka la] Mepolizumab for Injection Read this carefully before you start taking NUCALA and each time you
More informationEMERGENCY PHONE: or (651) (24 hours)
Material Safety Data Sheet Copyright, 2006, 3M Company. All rights reserved. Copying and/or downloading of this information for the purpose of properly utilizing 3M products is allowed provided that: (1)
More informationFor the Patient: Trastuzumab emtansine Other names: KADCYLA
For the Patient: Trastuzumab emtansine Other names: KADCYLA Trastuzumab emtansine (tras tooz' ue mab em tan' seen) is a drug that is used to treat some types of cancer. Trastuzumab emtansine is a clear
More informationPackage leaflet: Information for the user. Melatonin Pharma Nord 3 mg, film-coated tablets melatonin
Package leaflet: Information for the user Melatonin Pharma Nord 3 mg, film-coated tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information
More informationSAFE? ALL YOU NEED ONE LAB
Safety tests 1 Is your product SAFE? 2 Client orientation - Mainly In- vivo Tests - Clinical control - Volunteers: - 3000 volunteers database - Caucasian, negroid, asian - Several skin types - Fast recruitment
More informationEduardo Costa Sa, Mario Ferreira Junior, Lys Esther Rocha
Eduardo Costa Sa, Mario Ferreira Junior, Lys Esther Rocha eduardocs@usp.br Faculdade de Medicina e Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, SP, Brazil. The visual fatigue associated
More informationSAFETY DATA SHEET. SSS Sunray Non-Ammoniated Glass Cleaner
SAFETY DATA SHEET SSS Sunray Non-Ammoniated Glass Cleaner Date Prepared : 05/07/2015 SDS No : Triple S_Sunray 1. PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME: SSS Sunray Non-Ammoniated Glass Cleaner
More informationWhat do I need to tell my doctor BEFORE I take this drug?
PATIENT & CAREGIVER EDUCATION Pembrolizumab Brand Names: US Keytruda Brand Names: Canada Keytruda What is this drug used for? It is used to treat cancer. What do I need to tell my doctor BEFORE I take
More informationRecurrent Corneal Erosion Syndrome
Eye Care Centre NHS Foundation Trust Recurrent Corneal Erosion Syndrome Information for patients Every Matters 1 What is recurrent corneal erosion syndrome? Recurrent corneal erosion syndrome is repeated
More informationMEDICAL QUESTIONNAIRE (female)
MEDICAL QUESTIONNAIRE (female) Slievemore Clinic, Old Dublin Road, Stillorgan, Co. Dublin. Tel 01-2000501 The appointment comprises of a discussion about this questionnaire and a subsequent medical examination.
More informationMATERIAL SAFETY DATA SHEET ULTRAFIL
Page 1 of 6 Section 01 - Product Information Identification of the company: Dryvit Systems, Inc. World Headquarters 1 Energy Way West Warwick, RI 02893 USA Telephone: +1 401 822 4100 Contact: EH&S Manager
More informationglaucoma a closer look
0AMERICAN ACADEMY OF OPHTHALMOLOGY The Eye M.D. Association 2012-2013 glaucoma a closer look WHAT IS GLAUCOMA? < Glaucoma is a disease of the optic nerve the part of the eye that carries the images we
More informationSAMARIUM COBALT SAFETY DATA SHEET DATE OF LAST REVISION: 07/01/15. Section 1: Identification
Section 1: Identification DATE OF LAST REVISION: 07/01/15 Product Name: Samarium Cobalt CAS Number: 12017-68-4 / EC Number: 231-625-7 Company: Angstrom Sciences, Inc. 40 South Linden Street Duquesne, PA
More informationEmotional Relationships Social Life Sexually Recreation
Name Date Address City State Zip Married Single Partner Divorced Widowed Date of Birth SS# Email Work Phone Home Phone Cell Phone Occupation Referred by Emergency Contact Family Physician Contact May we
More informationMATERIAL SAFETY DATA SHEET Gantz Road Grove City, OH Shoreline Court, Suite 101 South San Francisco, CA 94080
MATERIAL SAFETY DATA SHEET MANUFACTURER: DISTRIBUTOR: Tosoh Bioscience, Inc. 3600 Gantz Road Grove City, OH 43123 Tosoh Bioscience, Inc. 6000 Shoreline Court, Suite 101 South San Francisco, CA 94080 PRODUCT
More informationENIDIN EYE DROPS [brimonidine tartrate]
ENIDIN EYE DROPS [brimonidine tartrate] Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ENIDIN eye drops, including how to use the eye It does not
More informationPsychiatric Evaluation Intake Form
Patient Contact Information Psychiatric Evaluation Intake Form Patient Name: Date of Birth: Age: Last First MI Address: Contact phone number: Email address: Emergency Contact/Number/Relationship: Primary
More informationSPECIAL SENSES. Anatomy & Physiology
SPECIAL SENSES Anatomy & Physiology BELL WORK: DEFINE LACRIMAL ACHROMATIC OTOSCOPE TENNITIS VERTIGO STANDARD 25) Define key terms associated with vision disorders, ear disorders, nose disorders, and mouth
More informationFuel your determination to live longer with KYPROLIS. Look inside to learn more.
F O R R E L A P S E D MULT IP L E M Y E L OM A APPROVED USES KYPROLIS is a prescription medication used to treat patients with relapsed or refractory multiple myeloma who have received one to three previous
More informationMaterial Safety Data Sheet Medi-Aire, Fresh Air
Material Safety Data Sheet Medi-Aire, Fresh Air Version: US Date Prepared: 03/02/06 Revision No. 2 1. Product and Company Identification Product Name: Medi-Aire, Fresh Air, Lemon, or Unscented Product
More informationSymptom Questionnaire
Symptom Questionnaire The following questionnaire is a general assessment of your health developed by Dr Royal Lee D.D.S. Each grouping represents a particular area of your body that may be causing you
More informationClinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services SMOKING CESSATION Introduction NICE recommends that Nicotine Replacement Therapy (NRT), bupropion [Zyban ] and
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study Synopsis for Public Disclosure This clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data. The synopsis
More informationMATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET Date revised: 5/30/2012 Conforms to 93/112/EC and ISO 11014-1 1. Chemical Product and Company Identification Product Name: Uniscint BD Product Number: LS-276 Chemical Names/Description:
More informationPackage leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride
Package leaflet: Information for the user Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important
More informationElectrohypersensitivity a moving target from VDT to WiFi
Electrohypersensitivity a moving target from VDT to WiFi Kjell Hansson Mild 1 and Monica Sandström 2 1. Dept. of Radiation Sciences, 2. Dept. of Occup. and Environ. Medicine, Umeå University, Umeå, Sweden
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate
PACKAGE LEAFLET: INFORMATION FOR THE USER GRAZAX 75,000 SQ-T oral lyophilisate Standardised allergen extract of grass pollen from Timothy (Phleum pratense) Read all of this leaflet carefully before you
More informationEthylene Oxide
Ethylene Oxide 75-21-8 Hazard Summary The major use of ethylene oxide is as a chemical intermediate in the manufacture of ethylene glycol. Ethylene oxide is also used as a sterilizing agent for medical
More informationDuPont StoneTech Professional POLISHING POWDER 900
This SDS adheres to the standards and regulatory requirements of the United States and may not meet the regulatory requirements in other countries. SECTION 1. PRODUCT AND COMPANY IDENTIFICATION Product
More informationSmoke inhalation damages the body by simple asphyxiation (lack of oxygen), chemical irritation, chemical asphyxiation, or a combination of these.
Print Close 2011 WebMD, LLC. All rights reserved. Smoke Inhalation Recommend 13 Medical Author: Christopher P Holstege, MD Medical Editor: Melissa Conrad Stöppler, MD Smoke Inhalation Overview Smoke Inhalation
More informationAmlodipine and Celecoxib
PATIENT & CAREGIVER EDUCATION Amlodipine and Celecoxib Warning This drug may raise the chance of heart and blood vessel side effects like heart attack and stroke. If these happen, they can be deadly. The
More informationThe Throat. Image source:
The Throat Anatomy Image source: http://anatomyforlayla.blogspot.co.za/2007/04/blog-post.html The Throat consists of three parts: 1. The Nasopharynx is the upper part of the throat and it is situated behind
More informationFrequently asked questions about wildfire smoke and public health
PUBLIC HEALTH DIVISION http://public.health.oregon.gov Frequently asked questions about wildfire smoke and public health Wildfire smoke Q: Why is wildfire smoke bad for my health? A: Wildfire smoke is
More informationPHYSIOTHERAPIST. Date of last visit MASSAGE THERAPIST. Date of last visit SPECIALISTS. Date of last visit WHAT ARE YOUR PRIMARY HEALTH CONCERNS?
2 PHYSIOTHERAPIST Date of last visit MASSAGE THERAPIST Date of last visit SPECIALISTS Date of last visit WHAT ARE YOUR PRIMARY HEALTH CONCERNS? WHAT IS THE PRIMARY REASON YOU ARE SEEKING CONSULTATION/TREATMENT?
More information3 DOSAGE FORMS AND STRENGTHS
PATADAY- olopatadine hydrochloride solution/ drops Alcon Laboratories, Inc. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PATADAY safely
More informationNJSP HMRU June 10, 2004
June 10, 2004 Chemical-Bio Agents Module 3 Overview 1 Objectives Student will: Demonstrate ability to recognize signs and symptoms of chemical agent exposure Describe how to protect oneself against chemical
More informationEye Floaters Eye Feel Heavy Tired Headaches
Eye Floaters Eye Feel Heavy Tired Headaches I do feel sick every now and then probably due to me being tired alot, doesnt effect much else except make my eyes feel heavy. Pressure in my nose, burning and
More informationChapter 11 Tobacco Section 1: Tobacco Use
Chapter 11 Tobacco Section 1: T obacco Use Do Now 1. Read the article The facts behind e-cigarettes and their health risks 2. Annotate 3. Summary Key Terms Ø Nicotine Ø Carcinogen Ø Tar Ø Carbon monoxide
More informationRaleigh Psychiatric Associates, P. A Browning Place, Suite 201 Raleigh, NC Telephone Fax
James E. Bellard, M.D.,P.A. Thomas R. Spruill, M.D.,P.A. Philip L. Hillsman, M.D., F.A.P.A, Cherry Chevy, M.D. Rhonda H. Stahl, M.D. Zachary. W. Feldman, M.D. Alyssa Williams George, M.D. Dana C. Fennell,
More information1 I *********IF YOU ARE NOT ON ALLERGY SHOTS PLEASE SKIP THIS SECTION AND MOVE TO PAGE 2********* NAME: AGE: ---- ID (For Office Use Only):
NAME: AGE: ---- Date of Appointment:. ID (For Office Use Only): RETURN VISIT Date of Visit: Main Reason for visit: Reevaluation Family Doctor: Symptoms worse _ New problem _ Yearly follow up _ Follow up/office
More informationMATERIAL SAFETY DATA SHEET
MSDS Number : PD-004E 1/7 MATERIAL SAFETY DATA SHEET 1. CHEMICAL PRODUCT AND COMPANY IDENTIFICATION MANUFACTURER : FUJIFILM ELECTRONIC MATERIALS CO., LTD. 15TH ARAI BLDG. 19-20, JINGUHMAE 6-CHOME, SHIBUYA-KU,
More information